William L. Dahut
Senior Investigator, CCR Clinical Director, CCR Sc
Genitourinary Malignancies Branch
National Cancer Institute
United States of America
Biography
Dr. Dahut received his M.D. from Georgetown University in Washington, DC. He completed clinical training in internal medicine at the National Naval Medical Center in Bethesda, MD, followed by training in hematology and medical oncology at the Bethesda Naval Hospital and the Medicine Branch of the NCI. Dr. Dahut worked as an attending physician in the NCI-Navy Medical Oncology Branch until 1995. He then joined the faculty of the Lombardi Cancer Center at Georgetown University before returning to the former NCI Medicine Branch in 1998 as head of the prostate cancer clinic. In 2002, Dr Dahut became Chief of the GU/GYN Clinical Research Section in the Medical Oncology Clinical Research Unit. Dr. Dahut's primary research interest has been in the development of novel therapeutic strategies for the treatment of adenocarcinoma of the prostate. As Section Chief, Dr. Dahut oversees the Branch’s clinical/translational prostate cancer research program, which emphasizes new approaches to the treatment, diagnosis and prognostic evaluation of prostate cancer with the goal to increase the precision in which therapeutic decisions are made for patients with primary and metastatic prostate cancer.
Research Interest
1) Prostate cancer 2) Androgen Receptor 3) Clinical Trials 4) Angiogenesis 5) Chemotherapy 6) Immunotherapy 7) The Development of Novel Therapeutics for Prostate Cancer 8) Clinical Trials Using Antiangiogenic Agents 9) Thalidomide in the Treatment of Prostate Cancer 10) Small Molecules in the Treatment of Prostate Cancer 11) Vaccines in the Treatment of Prostate Cancer.
Publications
-
Androgen deprivation therapy for prostate cancer.
-
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.
-
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.